Academic Programmes Division, Singapore Institute of Technology, Singapore, Singapore.
BMC Health Serv Res. 2012 Aug 8;12:243. doi: 10.1186/1472-6963-12-243.
Cardiac rehabilitation (CR), a multidisciplinary program consisting of exercise, risk factor modification and psychosocial intervention, forms an integral part of managing patients after myocardial infarction (MI), revascularization surgery and percutaneous coronary interventions, as well as patients with heart failure (HF). This systematic review seeks to examine the cost-effectiveness of CR for patients with MI or HF and inform policy makers in Singapore on published cost-effectiveness studies on CR.
Electronic databases (EMBASE, MEDLINE, NHS EED, PEDro, CINAHL) were searched from inception to May 2010 for published economic studies. Additional references were identified through searching bibliographies of included studies. Two independent reviewers selected eligible publications based on the inclusion/exclusion criteria. Quality assessment of economic evaluations was undertaken using Drummond's checklist.
A total of 22 articles were selected for review. However five articles were further excluded because they were cost-minimization analyses, whilst one included patients with stroke. Of the final 16 articles, one article addressed both centre-based cardiac rehabilitation versus no rehabilitation, as well as home-based cardiac rehabilitation versus no rehabilitation. Therefore, nine studies compared cost-effectiveness between centre-based supervised CR and no CR; three studies examined that between centre- and home based CR; one between inpatient and outpatient CR; and four between home-based CR and no CR. These studies were characterized by differences in the study perspectives, economic study designs and time frames, as well as variability in clinical data and assumptions made on costs. Overall, the studies suggested that: (1) supervised centre-based CR was highly cost-effective and the dominant strategy when compared to no CR; (2) home-based CR was no different from centre-based CR; (3) no difference existed between inpatient and outpatient CR; and (4) home-based programs were generally cost-saving compared to no CR.
Overall, all the studies supported the implementation of CR for MI and HF. However, comparison across studies highlighted wide variability of CR program design and delivery. Policy makers need to exercise caution when generalizing these findings to the Singapore context.
心脏康复(CR)是一个多学科的项目,由运动、危险因素修正和心理社会干预组成,是管理心肌梗死(MI)、血管重建手术和经皮冠状动脉介入治疗以及心力衰竭(HF)患者的重要组成部分。本系统评价旨在检查 CR 对 MI 或 HF 患者的成本效益,并为新加坡的决策者提供关于 CR 的已发表成本效益研究的信息。
从开始到 2010 年 5 月,我们在电子数据库(EMBASE、MEDLINE、NHS EED、PEDro、CINAHL)中搜索已发表的经济研究。通过搜索纳入研究的参考文献,确定了其他参考文献。两名独立评审员根据纳入/排除标准选择合格的出版物。使用 Drummond 清单对经济评估的质量进行评估。
共选择了 22 篇文章进行综述。然而,由于其中 5 篇文章是成本最小化分析,1 篇文章包括中风患者,因此进一步排除了 5 篇文章。在最终的 16 篇文章中,有 1 篇文章同时涉及中心型心脏康复与无康复、以及家庭型心脏康复与无康复的比较。因此,9 项研究比较了中心型监督式 CR 与无 CR 的成本效益;3 项研究比较了中心型与家庭型 CR 的成本效益;1 项研究比较了住院和门诊 CR 的成本效益;4 项研究比较了家庭型 CR 与无 CR 的成本效益。这些研究的特点是研究视角、经济研究设计和时间框架的差异,以及临床数据和成本假设的可变性。总体而言,这些研究表明:(1)与无 CR 相比,监督式中心型 CR 具有高度的成本效益和主导地位;(2)家庭型 CR 与中心型 CR 无差异;(3)住院和门诊 CR 之间无差异;(4)与无 CR 相比,家庭型方案通常具有成本效益。
总体而言,所有研究都支持 MI 和 HF 患者实施 CR。然而,研究之间的比较突出了 CR 项目设计和实施的广泛可变性。政策制定者在将这些发现推广到新加坡背景时需要谨慎。